Research and policy priorities for addressing prenatal exposure to opioids in Alaska
International Journal of Circumpolar Health, 2019 The current opioid crisis in Alaska and the USA will negatively affect the health and wellbeing of future generations. The increasing number of infants born with neonatal opioid withdrawal syndrome (NOWS) has had a profound impact on families, health ...
Rosalyn Singleton +9 more
doaj +1 more source
Challenges and Resources Available for Mothers in Opiate Recovery: A Qualitative Study
Open Journal of Occupational Therapy, 2018 Background: Opiate abuse and addiction in women during childbearing years has led to a sharp increase in neonatal abstinence syndrome (NAS). Babies born with NAS are at risk for significant health and developmental deficits.
Michelle Suarez +2 more
doaj +1 more source
Preconception Care of Women on Prescribed Opioids [PDF]
, 2017 The landmark 2015 report from the Center for Disease Control (CDC) posited that too many women of reproductive age received prescribed opioids. This is significant because fetal exposure to a known teratogen can have catastrophic outcomes.
Norwick, Rebecca-Maria
core +1 more source
Early Treatment for Neonatal Abstinence Syndrome: A Palliative Approach. [PDF]
, 2016 Objective To describe medical, safety, and health care utilization outcomes associated with an early treatment model for neonatal opioid withdrawal.
Chen, Liwei +7 more
core +1 more source
Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. [PDF]
, 2008 OBJECTIVE: The objective of the study was to identify maternal variables predicting length of treatment for neonatal abstinence syndrome (NAS). STUDY DESIGN: This was a retrospective cohort study of infants treated for NAS during 2000-2006 whose mothers ...
Baxter, Jason K. +5 more
core +2 more sources
Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes. [PDF]
, 2018 BACKGROUND: Methadone and buprenorphine are recommended to treat opioid use disorders during pregnancy. However, the literature on the relationship between longer-term effects of prenatal exposure to these medications and childhood development is both ...
Coyle, Mara G. +8 more
core +1 more source
Population Pharmacokinetic and Pharmacodynamic Analysis of Buprenorphine for the Treatment of Neonatal Abstinence Syndrome [PDF]
, 2017 Neonatal abstinence syndrome (NAS) is a condition affecting newborns exposed to an opioid in utero. Symptoms of NAS include excessive crying, poor feeding, and disordered autonomic control.
Adeniyi-Jones, MD, Susan C. +4 more
core +1 more source
Buprenorphine in Neonatal Abstinence Syndrome [PDF]
Clinical Pharmacology & Therapeutics, 2017 Infants exposed in utero to opioids will demonstrate a withdrawal syndrome known as neonatal abstinence syndrome (NAS). Buprenorphine is a long‐acting opioid with therapeutic use in medication‐assisted treatment of opioid dependency in adults and adolescents.
openaire +2 more sources
Voluntary Sterilization of Inmates for Reduced Prison Sentences [PDF]
, 2018 In May 2017, a Tennessee judge issued a standing order allowing inmates to receive thirty days’ jail credit in exchange for undergoing a voluntary sterilization procedure.
Adams, Elise B.
core +1 more source
Pakistan Journal of Medicine and DentistryThis case report delves into the clinical presentation, examination and management of a neonate from Pakistan, diagnosed with NEONATAL ABSTINENCE SYNDROME(NAS) at DarulSehat.
Saba Fareed +6 more
doaj +1 more source